These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 28442749)

  • 1. Identification of drug candidates that enhance pyrazinamide activity from a clinical compound library.
    Niu H; Ma C; Cui P; Shi W; Zhang S; Feng J; Sullivan D; Zhu B; Zhang W; Zhang Y
    Emerg Microbes Infect; 2017 Apr; 6(4):e27. PubMed ID: 28442749
    [No Abstract]   [Full Text] [Related]  

  • 2. Pyrazinamide: a frontline drug used for tuberculosis. Molecular mechanism of action resolved after 50 years?
    Kalinda AS; Aldrich CC
    ChemMedChem; 2012 Apr; 7(4):558-60. PubMed ID: 22241617
    [No Abstract]   [Full Text] [Related]  

  • 3. Synergistic activities of clarithromycin and pyrazinamide against Mycobacterium tuberculosis in human macrophages.
    Mor N; Esfandiari A
    Antimicrob Agents Chemother; 1997 Sep; 41(9):2035-6. PubMed ID: 9303411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simple fibroblast-based assay to test the pyrazinamide susceptibility of Mycobacterium tuberculosis.
    Takii T; Hamasaki S; Hirano K; Abe C; Onozaki K
    Antimicrob Agents Chemother; 2005 Feb; 49(2):804-7. PubMed ID: 15673774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility testing of Mycobacterium tuberculosis to pyrazinamide.
    The Editors
    J Med Microbiol; 2002 Jan; 51(1):11-12. PubMed ID: 11800467
    [No Abstract]   [Full Text] [Related]  

  • 6. Pyrazinamide Is Active against Mycobacterium tuberculosis Cultures at Neutral pH and Low Temperature.
    den Hertog AL; Menting S; Pfeltz R; Warns M; Siddiqi SH; Anthony RM
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4956-60. PubMed ID: 27270287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of antitubercular agents of the 2d series: ethionamide, ethoxyd cycloserine and pyrazinamide on the development of drug resistance of Mycobacterium tuberculosis to tubazide and phthivazide].
    Makeeva OO
    Farmakol Toksikol; 1969; 32(2):202-5. PubMed ID: 4977183
    [No Abstract]   [Full Text] [Related]  

  • 8. pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis isolates in Portugal.
    Portugal I; Barreiro L; Moniz-Pereira J; Brum L
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2736-8. PubMed ID: 15215139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microbiology. Pyrazinamide--old TB drug finds new target.
    Cole ST
    Science; 2011 Sep; 333(6049):1583-4. PubMed ID: 21921185
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of the microscopic observation drug susceptibility assay for detection of Mycobacterium tuberculosis resistance to pyrazinamide.
    Ghiraldi LD; Campanerut PA; Spositto FL; Sato DN; Leite CQ; Hirata M; Hirata RD; Cardoso RF
    Clin Microbiol Infect; 2011 Dec; 17(12):1792-7. PubMed ID: 21595790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of weak acids, UV and proton motive force inhibitors on pyrazinamide activity against Mycobacterium tuberculosis in vitro.
    Wade MM; Zhang Y
    J Antimicrob Chemother; 2006 Nov; 58(5):936-41. PubMed ID: 16950824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the BacT/ALERT PZA kit in comparison with the BACTEC 460TB PZA for testing Mycobacterium tuberculosis susceptibility to pyrazinamide.
    Aragón LM; Garrigó M; Moreno C; Español M; Coll P
    J Antimicrob Chemother; 2007 Sep; 60(3):655-7. PubMed ID: 17615155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyrazinamide resistance determined by liquid culture at low pH better correlates with genetic mutations in MDR tuberculosis isolates.
    Pang Y; Wang Z; Zheng H; Song Y; Wang Y; Zhao Y
    J Microbiol Methods; 2015 Dec; 119():142-4. PubMed ID: 26506283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Varying effects of common tuberculosis drugs on enhancing clofazimine activity in vitro.
    Zhang S; Shi W; Feng J; Zhang W; Zhang Y
    Emerg Microbes Infect; 2017 Apr; 6(4):e28. PubMed ID: 28442751
    [No Abstract]   [Full Text] [Related]  

  • 15. Mode of action of pyrazinamide: disruption of Mycobacterium tuberculosis membrane transport and energetics by pyrazinoic acid.
    Zhang Y; Wade MM; Scorpio A; Zhang H; Sun Z
    J Antimicrob Chemother; 2003 Nov; 52(5):790-5. PubMed ID: 14563891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Specificity of antituberculous action in vitro of pyrazine-2-carboxylic acid derivatives].
    Pavlov EP
    Probl Tuberk; 1971; 49(7):76-9. PubMed ID: 5004351
    [No Abstract]   [Full Text] [Related]  

  • 17. Non-
    Werngren J; Alm E; Mansjö M
    J Clin Microbiol; 2017 Jun; 55(6):1920-1927. PubMed ID: 28404681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyrazinamide resistance in Mycobacterium tuberculosis fails to bite?
    den Hertog AL; Sengstake S; Anthony RM
    Pathog Dis; 2015 Aug; 73(6):ftv037. PubMed ID: 25994506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycobacterium tuberculosis pncA Polymorphisms That Do Not Confer Pyrazinamide Resistance at a Breakpoint Concentration of 100 Micrograms per Milliliter in MGIT.
    Whitfield MG; Warren RM; Streicher EM; Sampson SL; Sirgel FA; van Helden PD; Mercante A; Willby M; Hughes K; Birkness K; Morlock G; van Rie A; Posey JE
    J Clin Microbiol; 2015 Nov; 53(11):3633-5. PubMed ID: 26292310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyrazinamide resistance in multidrug-resistant strains of Mycobacterium tuberculosis isolated in Abkhazia.
    Pardini M; Varaine F; Hewison C; Iona E; Pataracchia M; Orefici G; Fattorini L
    J Chemother; 2007 Feb; 19(1):106-7. PubMed ID: 17309862
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.